
Commentary|Podcasts|July 29, 2025
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
Experts discuss groundbreaking Hot Line trials at the European Society of Cardiology Congress 2025, offering insights into the latest cardiovascular research.
Advertisement
In this episode, Kaitlin Hile, PharmD, BCCP; Robert Page, PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP; and Robert DiDomenico, PharmD, FCCP, FHFSA, FACC, sat down with host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-cards), CACP, for an exciting discussion of several Hot Line trials at the upcoming European Society of Cardiology Congress 2025.
Learn more about the ESC Congress 2025 Hot Line
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
2
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
3
From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
4
FDA Grants Orphan Drug Designation to Zavabresib for the Treatment of Myelofibrosis
5





















